‘I think this is already in the U.S.,’ Dr. Scott Gottlieb says of new U.K. Covid strain
Former FDA chief Dr. Scott Gottlieb warned that the highly contagious, new mutation of Covid-19 found in the United Kingdom...
Eli Lilly and Co
Treasury yields fall despite stimulus progress as virus concerns persist
Treasury yields fall despite stimulus progress as virus concerns persistSearch quotes, news & videos Source link
Treasury yields dip ahead of key economic data and Fed chair’s speech
U.S. Treasury yields fell on Thursday ahead of key economic data due to be released later in the day and...
Eli Lilly still confident in benefits of Covid antibody treatment despite end to hospital study
Eli Lilly Chairman and CEO Dave Ricks told CNBC on Tuesday that he believes the company's coronavirus antibody treatment will still...
Treasury yields sink as stimulus stalemate continues
U.S. Treasury yields fell on Monday as hopes waned that a stimulus deal in Washington would be signed before the...
Treasury yields edge lower as stimulus talks drag
U.S. government debt prices were slightly higher Thursday morning as talks between Treasury Secretary Steven Mnuchin and House Speaker Nancy...
Treasury yields climb as stimulus hopes return to the fore
U.S. government debt prices were lower Monday morning amid renewed optimism that a coronavirus aid package could be agreed in...
Coronavirus clinical trials are pausing over safety concerns – here’s what that means
Coronavirus clinical trials from drug giants Johnson & Johnson and Eli Lilly hit a snag this week after safety monitors...
Ex-CDC director: Pauses to coronavirus drug trials give ‘reassurance’ that corners aren’t being cut
The recent pauses to clinical trials examining a potential coronavirus vaccine and therapeutic due to safety concerns should not cause...
U.S. pauses Eli Lilly’s trial of a coronavirus antibody treatment over safety concerns
In this May 2020 photo provided by Eli Lilly, researchers prepare mammalian cells to produce possible COVID-19 antibodies for testing...
Gilead CEO: ‘We have ample supply’ of remdesivir for hospitalized coronavirus patients
Gilead Sciences will have sufficient global supply of its coronavirus treatment remdesivir by the end of October, CEO Daniel O'Day told CNBC...
U.S. government begins two trials testing Eli Lilly’s coronavirus antibody drug
In this May 2020 photo provided by Eli Lilly, researchers prepare mammalian cells to produce possible COVID-19 antibodies for testing...
Bill Gates says there could be a ‘substantial’ reduction in coronavirus death rate by end of 2020
Bill Gates addresses a virtual Covid-19 conference hosted by the International Aids Society. July 11, 2020International Aids Society HandoutMicrosoft founder...
